Physician profile
Daniel Kim
NPI 1831123116
$1,301.96
in general payments reported to CMS, 2019-2025
21 companies · $389 in 2025
The $389 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $14.50 · 2021: $63.22 · 2022: $195 · 2023: $259 · 2024: $253 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $901.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $152.50 | 2024-2025 | Keytruda |
| Innovation Technologies INC | $143.56 | 2023 | Irrisept |
| Abbvie INC. | $125.27 | 2024 | |
| Medtronic Vascular, INC. | $115.76 | 2019 | |
| Tolmar, INC. | $111.35 | 2024-2025 | Eligard |
| Sumitomo Pharma America, INC. | $98.24 | 2023 | Gemtesa |
| Urogen Pharma, INC. | $87.00 | 2024-2025 | |
| Integra Lifesciences Corporation | $69.53 | 2022 | |
| Janssen Biotech, INC. | $56.15 | 2025 | Erleada, Carvykti, Rybrevant |
| Ferring Pharmaceuticals INC. | $52.27 | 2025 | Adstiladrin |
| Endo Pharmaceuticals INC. | $46.20 | 2021 | |
| Medacta USA, INC. | $45.39 | 2022 | |
| Coloplast Corp | $38.10 | 2022-2023 | Titan |
| Alcon Vision LLC | $35.95 | 2022-2025 | Clareon Panoptix Pro |
| Teleflex LLC | $24.14 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $21.96 | 2025 | V.A.C. Veraflo Cleanse Choice |
| Endo USA, INC. | $19.01 | 2025 | Aveed, Xiaflex |
| Horizon Therapeutics Plc | $17.02 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $15.80 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $14.50 | 2020 | |
| Karl Storz Endoscopy-America | $12.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.